U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.
U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.
Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process?
Specific contributions to a scientific article entitle the contributor to be included as an author; requests for authorship by those who have not made those specific contributions are unethical.
The bias for publishing positive clinical-research results can cause physicians to question journal articles as dependable sources of product information.
Physicians’ ethical obligations to disclose conflicts of interest to patients and to obtain their informed consent for treatment are particularly critical when proposed treatments are experimental.